Fibrotic lung toxicity induced by cytotoxic drugs, radiation and immunotherapy in patients treated for lung cancer

by Elena Bargagli, Viola Bonti, Alessandra Bindi, Vieri Scotti, Massimo Pistolesi, Luca Voltolini, Katia Ferrari
Published 2018-06-01

Chasing the Target: New Phenomena of Resistance to Novel Selective RET Inhibitors in Lung Cancer. Updated Evidence and Future Perspectives

by Sara Fancelli, Enrico Caliman, Francesca Mazzoni, Marco Brugia, Francesca Castiglione, Luca Voltolini, Serena Pillozzi, Lorenzo Antonuzzo
Published 2021-03-01

Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted Therapies

by Alberto D’Angelo, Navid Sobhani, Robert Chapman, Stefan Bagby, Carlotta Bortoletti, Mirko Traversini, Katia Ferrari, Luca Voltolini, Jacob Darlow, Giandomenico Roviello
Published 2020-11-01

Beyond Conventional: The New Horizon of Targeted Therapy for the Treatment of Advanced Non Small Cell Lung Cancer

by Alfredo Tartarone, Vittoria Lapadula, Concetta Di Micco, Gemma Rossi, Carlotta Ottanelli, Andrea Marini, Roberta Giorgione, Katia Ferrari, Martina Catalano, Luca Voltolini, Enrico Mini, Giandomenico Roviello
Published 2021-05-01

Gorham-Stout Disease Management during Pregnancy

by Elena Bargagli, Caterina Piccioli, Edoardo Cavigli, Marianna Scola, Elisabetta Rosi, Federico Lavorini, Luca Novelli, Dario Ugolini, Tommaso Notaristefano, Pieralli Filippo, Vittorio Miele, Camilla E. Comin, Massimo Pistolesi, Luca Voltolini
Published 2017-10-01